Page last updated: 2024-10-24

carbamazepine and Multiple Myeloma

carbamazepine has been researched along with Multiple Myeloma in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clarke, SJ1
Hickie, JB1
Enno, A1

Other Studies

1 other study available for carbamazepine and Multiple Myeloma

ArticleYear
Acute cardiac failure in multiple myeloma.
    The Medical journal of Australia, 1989, Sep-04, Volume: 151, Issue:5

    Topics: Carbamazepine; Cardiomyopathy, Dilated; Electrocardiography; Furosemide; Humans; Male; Melphalan; Mi

1989